Keiju Aokage Selected Research

Keiju Aokage Research Topics

Disease

41	Neoplasms (Cancer) 04/2022 - 09/2008
21	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 08/2007
15	Lung Neoplasms (Lung Cancer) 01/2022 - 08/2011
12	Adenocarcinoma of Lung 12/2022 - 04/2013
11	Adenocarcinoma 10/2021 - 09/2010
5	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2008
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 12/2015
3	Hypoxia (Hypoxemia) 05/2019 - 01/2018
3	Carcinoma (Carcinomatosis) 10/2016 - 09/2013
3	Heart Arrest (Cardiac Arrest) 09/2006 - 02/2005
2	Lymphatic Metastasis 03/2021 - 06/2015
2	Necrosis 01/2021 - 07/2019
2	Neuroendocrine Carcinoma 12/2020 - 12/2015
2	Idiopathic Pulmonary Fibrosis 09/2020 - 08/2020
2	Stomach Neoplasms (Stomach Cancer) 12/2018 - 04/2015
1	Extranodal Extension 12/2021
1	Hemorrhage 06/2021
1	Thromboembolism 06/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 06/2021
1	Anorexia 12/2020
1	Diarrhea 12/2020
1	Neutropenia 12/2020
1	Febrile Neutropenia 12/2020
1	Head and Neck Neoplasms (Head and Neck Cancer) 05/2019
1	Fistula 01/2019
1	Empyema 01/2019
1	Solitary Pulmonary Nodule 12/2018
1	Diabetes Mellitus 01/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 03/2017
1	Residual Neoplasm 02/2017
1	Colorectal Neoplasms (Colorectal Cancer) 11/2014

Drug/Important Bio-Agent (IBA)

11	Biological ProductsIBA 07/2019 - 08/2007
8	Cadherins (E-Cadherin)IBA 01/2021 - 09/2010
6	Carbonic Anhydrase IXIBA 01/2021 - 04/2013
5	ErbB Receptors (EGF Receptor)IBA 12/2021 - 08/2011
5	KalininIBA 07/2019 - 04/2011
5	ezrinIBA 01/2018 - 03/2015
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2008
3	AntibodiesIBA 04/2022 - 12/2015
3	CytokinesIBA 01/2021 - 04/2013
3	Indicators and Reagents (Reagents)IBA 01/2019 - 04/2013
3	Carcinoembryonic AntigenIBA 01/2017 - 04/2015
3	Heparin (Liquaemin)FDA LinkGeneric 09/2006 - 02/2005
3	low potassium dextran glucose solutionIBA 09/2006 - 02/2005
2	AlbuminsIBA 10/2022 - 01/2018
2	CateninsIBA 11/2021 - 04/2011
2	Immune Checkpoint InhibitorsIBA 01/2021 - 11/2020
2	VimentinIBA 01/2021 - 09/2013
2	NucleotidesIBA 01/2021 - 05/2018
2	Tyrosine Kinase InhibitorsIBA 09/2017 - 07/2016
2	Small Interfering RNA (siRNA)IBA 07/2016 - 03/2015
2	GemininIBA 01/2016 - 04/2011
2	Phosphotransferases (Kinase)IBA 12/2015 - 08/2011
1	C-Reactive ProteinIBA 10/2022
1	durvalumabIBA 04/2022
1	Aldehyde Dehydrogenase 1 FamilyIBA 04/2022
1	Mucin-1 (CA 15-3 Antigen)IBA 04/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	Neoplasm Antigens (Tumor Antigens)IBA 11/2021
1	osimertinibIBA 10/2021
1	xylometazoline (stas)IBA 07/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2021
1	Oxygen (Dioxygen)IBA 06/2021
1	NivolumabIBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 12/2020
1	Etoposide (VP 16)FDA LinkGeneric 12/2020
1	Irinotecan (Camptosar)FDA LinkGeneric 12/2020
1	Programmed Cell Death 1 ReceptorIBA 11/2020
1	LigandsIBA 11/2020
1	pirfenidoneIBA 08/2020
1	Glucose Transporter Type 1IBA 10/2019
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 10/2018
1	1-methyl-1-piperidinomethane sulfonateIBA 01/2018
1	Caveolin 1IBA 02/2017
1	Keratins (Keratin)IBA 02/2017
1	Growth Factor ReceptorsIBA 10/2016
1	Gefitinib (Iressa)FDA Link 07/2016
1	tyrosine receptor (receptor, tyrosine)IBA 12/2015
1	matrigelIBA 03/2015
1	Proteins (Proteins, Gene)FDA Link 03/2015
1	ClusterinIBA 07/2014
1	CaveolinsIBA 07/2014

Therapy/Procedure

12	Therapeutics 04/2022 - 03/2016
11	Lymph Node Excision (Lymph Node Dissection) 11/2022 - 07/2010
9	Segmental Mastectomy (Lumpectomy) 01/2022 - 11/2012
5	Pneumonectomy (Lung Volume Reduction) 12/2022 - 11/2012
4	Adjuvant Chemotherapy 12/2021 - 11/2014
4	Metastasectomy 05/2019 - 03/2017
3	Chemoradiotherapy 04/2022 - 12/2016
3	Drug Therapy (Chemotherapy) 08/2021 - 09/2008
3	Radiotherapy 03/2021 - 12/2016
3	Lung Transplantation 10/2009 - 04/2006
2	Gastrectomy 12/2018 - 07/2008
2	Heart Massage 09/2006 - 04/2006
1	Perioperative Period 06/2021
1	Combined Modality Therapy 03/2021
1	Immunotherapy 01/2021
1	Operative Surgical Procedures 12/2018